Optic Nerve Sheath Diameter in Patients With Intracranial Pathology
Ultrasonographic Assessment of the Optic Nerve Sheath Diameter in Patients With Intracranial Pathology
1 other identifier
observational
100
1 country
1
Brief Summary
Elevated intracranial pressure (ICP) is a common and potentially life threatening condition arising from a variety of pathological conditions. The ability to monitor ICP is a crucial aspect in the management of these patients. Currently, the diagnosis of whether ICP is elevated or not is determined either with clinical signs (headache, nausea and vomiting or visual disturbances) or from the changes in the preoperative neuroimaging modalities such as computerized tomography (CT scan) and/or magnetic resonance imaging (MRI). Recently, transorbital ultrasonography has gained popularity as a noninvasive bedside exam that has been shown to be useful in the diagnosis of raised ICP by evaluating the change in the optic nerve sheath diameter (ONSD). The aim of our study is to use transorbital ultrasound to evaluate ONSD changes in patients with intracranial pathology and to compare the changes in the ONSD before and after surgical intervention as well as between patients with and without clinical or radiological signs of increased ICP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 3, 2015
CompletedFirst Posted
Study publicly available on registry
February 12, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedAugust 28, 2023
August 1, 2023
8.3 years
February 3, 2015
August 24, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Optic Nerve Sheath Diameter, as measured by ultrasound of the optic nerve"
6-8 weeks
Interventions
Optic nerve sheath diameter will be measured by ultrasound preoperatively on the day of surgery, Immediate postoperative period (within 24 hours) or 6-8 weeks after surgery on the follow-up visit.
Eligibility Criteria
Intracranial pathology patients scheduled for elective or emergency surgery.
You may qualify if:
- Intracranial pathology patients scheduled for elective or emergency surgery.
- American Anesthesiologist Society physical status classification system (ASA) 1-4
You may not qualify if:
- history of Glaucoma,
- previous retinal surgery,
- optic neuritis,
- lack of informed consent,
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Toronto Western Hospital
Toronto, Ontario, M5T2S8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dinsmore Michael, MD
University Health Network, Toronto
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2015
First Posted
February 12, 2015
Study Start
February 1, 2015
Primary Completion
May 31, 2023
Study Completion
June 30, 2023
Last Updated
August 28, 2023
Record last verified: 2023-08